RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. M Ventures
M

M Ventures portfolio

M Ventures has 21 portfolio companies on record at Recent Funding, with 7 investments in the last 12 months.

Website: m-ventures.com.
Type: Corporate venture.
Portfolio on Recent Funding: 21.
Deals, last 12 months: 7.
Rounds led: 13 of 31.
Capital in their rounds: $1.54B.
Latest deal: T-Therapeutics · Nov 5, 2026.
About this page

It is a corporate venture investor based in Amsterdam, NL, founded in 2009. It led 13 of the 31 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (15) and AI infrastructure and compute (3). It has co-invested with Pfizer Venture Investments, Cambridge Innovation Capital and EQT Life Sciences, most often Pfizer Venture Investments (6 rounds).

About M Ventures

Firm type: Corporate venture.
Headquarters: Amsterdam, NL.
Founded: 2009.
Stages: Seed, Series A, Series B, Series C, Growth.
Sectors: Biotech, Cleantech, Cybersecurity, Deep Tech, Digital Health, FoodTech, Hardware, Healthtech, IoT, Medical Devices, New Materials, Semiconductors.
Leads rounds: No.
Portfolio companies: 124.
Exits: 9.
Rounds led: 17.

What M Ventures invests in

M Ventures recent investments

How M Ventures invests

StageDealsCapital in rounds
Series A 16 52%$433.71M
Series B+ 13 42%$1.08B
Seed 2 6%$24.87M
YearDealsCapital in rounds
2016 1 3%$16.06M
2017 2 6%$29M
2019 3 10%$40.75M
2020 3 10%$33.3M
2021 4 13%$360M
2022 3 10%$60M
2023 1 3%$72M
2024 5 16%$291.66M
2025 3 10%$225.5M
2026 6 19%$407.14M

M Ventures portfolio companies

CompanyRound with M VenturesTotal raisedLatest raise
TT-Therapeutics
Health and bio
Series B+ · $133M$283MNov 5, 2026
Series B+
NNouscom
Health and bio
Series B+ · $135.04M · lead$267.56MOct 19, 2026
Series B+
MMueon
AI infrastructure and compute
Series A · $65M$80.5MOct 15, 2026
Series A
TTRIMTECH Therapeutics
Health and bio
Seed · $14M$45MJun 23, 2026
Seed
FFuture Fertility
Health and bio
Series A · $4.1M · lead$4.1MApr 23, 2026
Series A
SStorm Therapeutics
Health and bio
Series B+ · $56M$102.06MApr 16, 2026
Series B+
FFoRx Therapeutics
Health and bio
Series A · $50M$60.87MDec 18, 2025
Series A
AActithera
Health and bio
Series A · $75.5M · lead$75.5MJul 9, 2025
Series A
BBiolinq
Health and bio
Series B+ · $100M$214.75MApr 22, 2025
Series B+
AAbselion
Health and bio
Series A · $8.86M · lead$8.86MDec 4, 2024
Series A
KKivu Bioscience
Health and bio
Series A · $92M$92MOct 28, 2024
Series A
FFormo
Commerce and retail
Series B+ · $61M$111MOct 9, 2024
Series B+
IiOnctura
Health and bio
Series B+ · $85.8M$108.24MJun 20, 2024
Series B+
LLabGenius
Health and bio
Series B+ · $44M · lead$73MMay 21, 2024
Series B+
MMetalenz
AI infrastructure and compute
Series B+ · $30M$70MMar 25, 2026
Series B+
WWiliot
AI infrastructure and compute
Series B+ · $200M$344MApr 27, 2026
round
NNeurable
Robotics and hardware
Series A · $6M · lead$43MDec 19, 2025
Series A
TTerragrit backerundisclosedSep 17, 2026
Seed
NNRG Therapeutics
Health and bio
backer$85MSep 8, 2025
Series B+
LLightcast
Health and bio
backer$27MApr 14, 2026
round
EEnara Bio
Health and bio
backer$32.5MJun 2, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 31 rounds on Recent Funding that name M Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists M Ventures, which is a subset of its real portfolio. API: /api/v1/investors/m-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy